New · The Impact Gap Report 2026: why physicians stopped reading pharma’s science. Get it free →
PubVisualPubVisual Book a Demo
Resources Blog About Contact Book a 30-Minute Demo →
PubVisual Smart Pathways

One publication. A line for every physician.

Smart Pathways turns your approved publication into branching journeys. Physicians choose the route and the depth; every stop along the way is already approved. You publish once. They each read it their own way.

One approved publication Mechanism of action Disease pathway Subgroup biology Primary endpoint Quality of life Real-world evidence Who benefits Dosing in practice Safety profile
Self-running · click a line to follow it
Before the first route
70%

70% of HCPs feel pharma reps don’t fully understand what they need.

Indegene · The Digitally Savvy HCP · 1,000 physicians

Hard to blame the rep. Veeva clocked the average face to face visit at about three minutes.

Three minutes is a greeting, not a needs assessment.

And every physician in the room needs something different from the same data.

So we flipped it

We let the physician show us.

One approved publication becomes a journey that adapts to specialty, interest, and depth. Her question first, always. The physician steers. The science follows.

Watch two physicians take the same paper ↓
PubVisual Smart Pathways

Built for medical teams at

Pfizer Genentech Bayer Johnson & Johnson Sanofi Amgen Roche Takeda Moderna Novartis
The list: Cardiology
Dr. Amara Osei Dr. Amara Osei
INTERVENTIONAL CARDIOLOGIST
“How does it actually work?”
Dr. Mateo Ruiz Dr. Mateo Ruiz
COMMUNITY CARDIOLOGIST
“Does the endpoint hold up?”
Dr. Ingrid Weber Dr. Ingrid Weber
HEART FAILURE SPECIALIST
“Which of my patients is this for?”

Same segment. Three different first questions.

The gap

Segments reach the specialty. Interest lives one level deeper.

Your targeting is already careful: specialty, region, stage of adoption. The list can say the specialty. It cannot say which physician wants the mechanism, which one wants the endpoint, and which one wants to know what changes for the patient in front of them.

That difference only shows up after they open it. Smart Pathways is built for exactly that moment: the same approved story, read three different ways.

Watch it happen

Two physicians open the same paper.

Tap one of them. The route, the order, and the stops rebuild around what they came to find out. Neither of them ever sees the other’s version, and neither one had to ask for it.

The same approved publicationOne source. One MLR review.

Self-running · tap a physician to take over

The mechanism readerHer route through the paper
1
2
3
Skipped without guilt:

Two journeys, one review. Both routes recombine the same approved modules, so nothing new is created and the review you already did covers them both. That is the whole idea: not one video for everyone, a way in for each physician.

Depth

Two minutes or the full picture. Their call.

A journey is not just which route. It is also how far to ride. Every Smart Pathways build carries three depths of the same approved story, and the reader decides how much science fits the moment.

2:00
The headline result
What changed in chronic heart failure
Primary endpoint
Study design
Quality of life data
Safety overview
Subgroup analyses
Mechanism deep dive
References, mapped to source
Between clinic patients
wants the takeaway

The 2-minute pass

One screen, one message: what changed and why it matters to her patients. Read, understood, back to clinic.

2sections shown
2:00reading time
1approved core

One approved core flexes to every attention span. Nobody gets the wrong version.

FREEThe Impact Gap Report · 2026

The document that settles the "is anyone reading this?" argument.

60+ studies on why physicians stopped reading pharma’s science, and the evidence for what works instead. Sourced, quotable, built for forwarding.

Get it now · free →
PubVisualby RedNovius
THE IMPACT GAP REPORT · 2026
Pharma keeps publishing. Physicians stopped reading.
What 60+ studies say about the gap between published and understood.
Compliance

One MLR review covers every journey, not one review per route.

Routes are not new content. They recombine modules from your approved core: the endpoint figure, the safety table, the expert clip. Different order, different depth, and no new claims, ever.

Everything stays modular and version-controlled, structured for review inside your existing Veeva workflow. Your reviewers see one core. Your physicians each get their own way through it.

The mechanism routeApproved once
MOA sequence
Endpoint figure
Safety table
Dosing card
Subgroup data
Expert clip

Same six modules. A different journey every time.

Where it runs

Wherever physicians already read.

One approved core follows your publication into the channels it already lives in: the portal, the inbox, the booth, and the iPad in the MSL’s bag.

The journey lives on your HCP portal, ready for the physician who arrives at midnight after clinic.

Pick your route: mechanism, outcomes, or patient fit
Continue the journey
“Two physicians walked me through the same piece and told me two different stories. That was the point.”
Medical Affairs Director · Cardiology
Book a demo

See your publication become a map.

Bring us your paper, your poster, or your value story. In 30 minutes we will sketch the routes your physicians would actually ride. Built to move through your review, not around it.

NEWFREE REPORT · 2026

Pharma keeps publishing. Physicians stopped reading.

The document that settles the argument: 57 pages of evidence on why your science isn’t landing, and what to do about it.

  • Every number for your next strategy meeting, on its own page, source linked
  • The final chapter: what the evidence says actually works
  • Built to forward · send it to whoever owns the publication plan
Get it now · free →
Questions

The ones we hear in every demo

If yours is not here, bring it along. The demo is a working session, not a pitch.

Book a 30-Minute Demo →

No. The physician steers. Routes respond to the choices they make inside the experience, not to a profile built about them. They stay in control of where to go and how deep to read.

No. Every route recombines modules from the approved core, so the review you already did covers each journey. A new claim would need new content, and we never create one.

As many as the science supports. Most teams start with three ways in: the mechanism, the outcomes, and patient fit, then let depth do the rest of the personalizing.

They share one approved core. Expert clips sit one tap from the data inside a route, and interactive moments can wait at any station. Alone or together, nothing gets rebuilt.

Your approved publication and your review process. We map the routes, build the modules, and structure everything for your Veeva workflow.